Last reviewed · How we verify
NCT07414771: INGA-MDP
Safety and Usability of the Inga Catheter for Labor Induction (INGA-MDP)
NA trial testing Cervical ripening, labor induction in Induction of Labor in 30 participants. Not yet recruiting.
30 September 2026
Quick facts
| Lead sponsor | Aalto University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 April 2026 |
| Primary completion | 30 September 2026 |
| Estimated completion | 31 March 2027 |
| Sites | 3 locations across Finland |
Drugs / interventions tested
- Cervical ripening, labor induction
Conditions studied
- Induction of Labor — all drugs for Induction of Labor →
- Cervical Ripening — all drugs for Cervical Ripening →
- Cervical Ripening and Induction of Labor — all drugs for Cervical Ripening and Induction of Labor →
Sponsor
Aalto University
Who can join
Adults 18 to 56, female only, with Induction of Labor or Cervical Ripening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical study is to evaluate a new mechanical balloon catheter (INGA) used to prepare the cervix for labor induction in pregnant women at term. The study aims to assess the safety, usability, and performance of the INGA catheter when used for cervical ripening before labor. Researchers will also collect feedback from healthcare professionals and participants about the use of the device. Participants are pregnant women at term with a single baby in a head-down position who meet the study eligibility criteria. Participants will: * have the INGA balloon catheter inserted as part of labor induction, * receive standard clinical care according to hospital practice, * provide information about their experience and outcomes related to the device. The results of this study will help determine whether the INGA catheter is safe and suitable for use in cervical ripening during labor induction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07414771
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Induction of Labor
Currently open trials in the same condition.
- NCT06803992 — Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter · Phase 4 · recruiting
Other Aalto University trials
Trials by the same sponsor.
- NCT07432282 — Evaluation of the INGA Sensor System for Fetal and Uterine Monitoring During Cervical Ripening · NA · not yet recruiting
- NCT07214948 — Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction · NA · not yet recruiting
- NCT06418321 — Early Identification of Age-related Hearing Impairment · completed
- NCT06585839 — Daring Birth - Digital Coaching Solution to Improve Childbirth Experience · NA · completed
- NCT05426265 — The Effects of Videogames on Depression Symptoms and Brain Dynamics · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07414771 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aalto University
- Last refreshed: 20 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07414771.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing